Erythromycin Prices

Erythromycin Price Trend, Index and Forecast

Track the latest insights on erythromycin price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Erythromycin Prices Outlook Q2 2025

• USA: US$ 169616/MT
• China: US$ 145847/MT
• Germany: US$ 179214/MT
• India: US$ 116918/MT
• Brazil: US$ 188248/MT

Erythromycin Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the second quarter of 2025, the erythromycin prices in the USA reached 169616 USD/MT in June. In the USA, erythromycin prices were influenced by steady demand from hospitals, clinics, and pharmaceutical distributors. Domestic production costs were shaped by feedstock availability and high energy and labor expenses. Imports from Asia supplemented supply, with landed costs impacted by shipping rates, port handling, and customs procedures. Regulatory compliance with Food and Drug Administration requirements for antibiotics added certification and testing expenses. Distribution through extensive healthcare networks, including warehousing and trucking, further contributed to overall procurement costs.

During the second quarter of 2025, erythromycin prices in China reached 145847 USD/MT in June. In China, erythromycin prices were driven by strong demand from domestic healthcare facilities and pharmaceutical manufacturers. Production economics were shaped by the availability of fermentation feedstocks, energy tariffs, and local labor costs. Export commitments to North America and Europe influenced domestic allocation, while logistics costs from inland transport and port congestion added further expenses. Environmental regulations on pharmaceutical production facilities increased compliance costs, while currency fluctuations against the US dollar influenced export competitiveness.

During the second quarter of 2025, the erythromycin prices in Germany reached 179214 USD/MT in June. In Germany, erythromycin prices were influenced by demand from the healthcare and pharmaceutical sectors. Supply was supported by both domestic production and imports, with freight charges, customs duties, and port handling shaping landed costs. Production costs were elevated due to high energy tariffs and labor expenses, while strict European Union pharmaceutical regulations required extensive certification and testing. Distribution expenses, including warehousing and trucking, added further costs, particularly for nationwide distribution to hospitals and pharmacies.

During the second quarter of 2025, the erythromycin prices in India reached 116918 USD/MT in June. In India, erythromycin prices were shaped by strong demand from hospitals, clinics, and generic drug manufacturers. Production costs were influenced by the availability of fermentation feedstocks, energy tariffs, and domestic labor conditions. Export activity to Europe, North America, and Africa impacted domestic supply. Logistics inefficiencies, including trucking delays and fuel costs, contributed to distribution expenses. Compliance with Good Manufacturing Practices and international pharmaceutical certifications added operational costs for manufacturers serving both local and global markets.

During the second quarter of 2025, the erythromycin prices in Brazil reached 188248 USD/MT in June. In Brazil, erythromycin prices were guided by demand from public and private healthcare providers. Heavy reliance on imports made costs sensitive to global shipping charges, port inefficiencies, and customs regulations. Currency volatility of the Brazilian real against the US dollar strongly impacted landed costs. Domestic distribution challenges, including long-haul trucking and infrastructure limitations, added to supply chain expenses. Regulatory compliance with national health agency standards further increased certification and testing costs for both importers and local distributors.

Erythromycin Prices Outlook Q2 2023

• USA: US$ 159,264/MT
• China: US$ 148,068/MT
• Germany: US$ 165,785/MT

The Q2 price of erythromycin in the United States reached 159,264 USD/MT in June 2023. Similarly, in China, the price trend for erythromycin was recorded 148,068 USD/MT in June 2023. Whereas Germany’s erythromycin prices accounted for 165,785 USD/MT in June 2023.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the erythromycin prices. 

Global Erythromycin Price Trend

The report offers a holistic view of the global erythromycin pricing trends in the form of erythromycin price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of erythromycin, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed erythromycin demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Erythromycin Price Trend

Q2 2025:

As per the erythromycin price index, European erythromycin prices were shaped by demand from the healthcare and pharmaceutical manufacturing sectors. Supply relied on both domestic production and imports from Asia, with landed costs impacted by shipping rates, port handling, and customs procedures. Production economics within the region were influenced by high energy tariffs and labor costs. Strict European Union pharmaceutical regulations required rigorous testing, certification, and traceability, adding compliance-related expenses. Inland logistics, including trucking and warehousing, further contributed to distribution costs across key markets.

Q1 2023:

European erythromycin prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed erythromycin price information for a comprehensive list of countries.

North America Erythromycin Price Trend

Q2 2025:

As per the erythromycin price index, in North America, erythromycin prices were driven by demand from hospitals, clinics, and pharmaceutical distributors. Domestic production was supplemented by imports, particularly from Asia, with freight charges, customs documentation, and port operations influencing procurement. Feedstock costs for fermentation-based production shaped domestic manufacturing economics, while compliance with strict Food and Drug Administration standards added testing and certification expenses. Inland distribution through extensive healthcare networks, including warehousing and long-haul trucking, further increased overall supply chain costs across the region.

Q12023:

The analysis of erythromycin prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific erythromycin historical data within the United States and Canada can also be provided.

Middle East and Africa Erythromycin Price Trend

Q2 2025:

As per the erythromycin price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences. A tight supply from refineries, exacerbated by maintenance rounds and unplanned outages, put pressure on prices. Simultaneously, demand from the agrochemical sector during the planting season contributed to price changes.

Q1 2023:

The report explores the erythromycin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on erythromycin prices for countries can also be provided.

Asia Pacific Erythromycin Price Trend

Q2 2025:

In Asia Pacific, erythromycin prices were influenced by strong demand from healthcare systems and generic drug manufacturers, with China and India playing major roles in production. Costs were shaped by feedstock availability for fermentation processes, energy tariffs, and labor conditions in pharmaceutical hubs. Export commitments to Europe and North America affected domestic allocation. Logistics expenses, including inland transportation and port congestion, further influenced supply chain economics. Regulatory compliance with international Good Manufacturing Practices and export certifications added operational costs for manufacturers.

Q1 2023:

The erythromycin pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This erythromycin price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Erythromycin Price Trend

Q2 2025:

In Latin America, particularly Brazil, erythromycin prices were guided by demand from public and private healthcare providers. Limited domestic production capacity increased reliance on imports, making costs sensitive to international shipping charges, port inefficiencies, and customs regulations. Currency volatility of the Brazilian real against the US dollar significantly shaped procurement expenses. Domestic logistics challenges, including long-haul trucking and infrastructure constraints, added further costs to distribution. Compliance with regulatory requirements set by national health authorities contributed to testing and certification expenses across the market.

Q1 2023:

The analysis of erythromycin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Erythromycin Price Trend, Market Analysis, and News

IMARC's latest publication, “Erythromycin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the erythromycin market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of erythromycin at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed erythromycin prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting erythromycin pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Erythromycin Industry Analysis

The global erythromycin market size reached USD 18.57 Billion in 2024. By 2033​, IMARC Group expects the market to reach USD 30.06 Billion, at a projected CAGR of 5.23% during 2025-2033.

• There is an increase in the utilization of erythromycin to treat respiratory tract infections (RTIs) like common cold, laryngitis, pharyngitis or tonsillitis, acute rhinitis, acute rhinosinusitis, acute otitis media, acute bronchitis, bronchiolitis, pneumonia, and tracheitis. People need effective antibiotics for fighting these infections, which is catalyzing the demand for erythromycin in the world.
• The growing demand for erythromycin on account of the rising geriatric population across the globe is offering a positive market outlook. Elderly people are more vulnerable to bacterial infections because of their weakened immune systems and comorbidities. In addition, common infections among elderly individuals include respiratory tract infections, skin infections, and urinary tract infections, all of which can be effectively treated with erythromycin. The population of people aged 60 years and plus is likely to hit 2.1 Billion in 2050 as stated by the United Nations (UN).
• The erythromycin demand is further impelled by the increasing awareness among individuals and healthcare providers about the diagnosis of bacterial infections. Better diagnostic techniques and the wide access to healthcare facilities are supporting earlier diagnoses and treatment of bacterial infections. Apart from this, public health initiatives that aims to educate populations about the importance of early diagnosis and treatment of infections contribute to an increase in the demand for erythromycin.
• Erythromycin is also becoming increasingly popular as companies are focusing on expanding their product portfolios and geographical presence through mergers and acquisitions (M&As) and partnerships. In addition, manufacturers are introducing new formulations and dosage forms of erythromycin, which are beneficial in enhancing its market accessibility to a larger population worldwide. 
• Erythromycin is widely utilized to treat various skin infections. It is mixed with tretinoin cream or benzoyl peroxide for treating acne problems. It can be applied to the skin or taken by mouth for controlling acne issues among individuals. People are facing these problems due to various factors such as poor dietary habits and environmental stressors.

Erythromycin News

The report covers the latest developments, updates, and trends impacting the global erythromycin market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in erythromycin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the erythromycin price trend.

Latest developments in the erythromycin industry:

• 1 September 2023, Zydus Lifesciences Limited received final approval from the United States Food and Drug Administration (USFDA) for erythromycin tablets USP, available in strengths of 250 mg and 500 mg (USRLD: erythromycin Tablets USP, 250 mg and 500 mg).

Product Description

Erythromycin is a bacteriostatic antibiotic being produced by a strain of Saccharopolyspora erythraea. It belongs to macrolides, a class of antibiotics. Others include, among others, azithromycin, clarithromycin, spiramycin, and others. It works by eliminating the bacteria or stops the growth of the bacteria by reducing the synthesis of vital proteins that are necessary for the bacteria to live. It is administrated through intravenous topical and eye drop preparations. In this regard, erythromycin prevents the elongation of polypeptide chains that are necessary in the bacterial growth and reproduction. It has been effective in a number of skin infections caused by susceptible bacteria such as impetigo and cellulitis. It is used to treat a sexually transmitted infection (STI) that is caused by chlamydia and gonorrhea bacteria.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of erythromycin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting erythromycin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The erythromycin price charts ensure our clients remain at the forefront of the industry.